Archive for the 'Devices and Technology' Category

Detecting Cancer with Carbon Nanotubes

A new development in cancer technology has made it possible for researchers to identify cancer cells with carbon nanotubes.  In recent announcement, a Harvard bioengineer and an MIT aeronautical engineer have developed a novel device that can identify single cancer cells in a blood sample, thus making it possible for doctors to quickly determine whether cancer has spread from its original site.

Continue reading ‘Detecting Cancer with Carbon Nanotubes’

Glucose Testing Gets Faster & Smarter

There is new hope for people suffering from diabetes! A new type of self-monitoring blood glucose sensor has been developed by the engineers and researchers at the Arizona State University’ Mayo Clinic in Arizona. With the number of people suffering from diabetes increasing by the day, it has already become the fifth leading cause of death in the United States. Diabetes leads to a higher risk for heart disease, blindness, kidney failure, lower extremity amputations and other chronic conditions.

Continue reading ‘Glucose Testing Gets Faster & Smarter’

Eye Circuitry to be Decoded with Help of New Microscope

In an example of how newer gadgets are advancing the field of medicine and health care, the development of a new type of microscope is going to help doctors and researchers to decode the mysteries behind the complex circuitry of the human eye.

Continue reading ‘Eye Circuitry to be Decoded with Help of New Microscope’

Seat of Fear Discovered in the Brain

Researchers have been long trying to figure out the basics of the very feeling of fear. Now, researchers from the Stanford University School of Medicine have discovered that stimulation of a distinct brain circuit that lies within a brain structure generally linked with fearfulness produces the opposite effect: Its activity, instead of triggering or increasing anxiety, counters it.

Continue reading ‘Seat of Fear Discovered in the Brain’

Top 10 Medical Device Venture Capital Deals of 2010

Fierce Medical Device’s first annual look at the top 10 VC deals of the year. Venture capital investment in the medical device industry fell 9 percent in 2010, ending the year as the fourth largest investment sector with $2.3 billion going into 324 deals. That’s up slightly over 2009, when medical devices ranked third among all industries.

Continue reading ‘Top 10 Medical Device Venture Capital Deals of 2010′

Nasal Delivery of Anti-vomiting Drug Patent Won

There are many reasons cancer patients can dread chemotherapy. It might kill their cancer, but those who go through it often wonder if the cure is just as bad as the disease. Among the uncomfortable symptoms is chemotherapy-induced vomiting. Ahmedabad, India-based Lincoln Pharmaceuticals has been granted a patent for its nasal drug delivery system (NDDS) of ondansetron hydrochloride, which prevents or arrests vomiting.

Continue reading ‘Nasal Delivery of Anti-vomiting Drug Patent Won’

Inhaled Insulin Closer to Reality

A Holy Grail in the drug-delivery business is the quest for a needle-free way for diabetics to take their insulin. Galway, Ireland-based Aerogen and San Francisco-based Dance Pharmaceuticals believe they have found the secret passageway–through the nose. And they’ve announced a drug-delivery partnership to develop an inhaled-insulin device.

Continue reading ‘Inhaled Insulin Closer to Reality’

Footstar to acquire CPEX’s Drug-Delivery Technology

A unit of Footstar Corp., a holding company, has agreed to acquire CPEX Pharmaceuticals for $76.6 million in cash. The bid is worth $27.25 a share–more than twice what it was a year ago as back-to-back quarterly profits helped fuel investor interest. CPEX focuses on what it calls a “drug delivery platform technology.” Platform, of course, is a key word that implies it’s not just a one-shot deal, but a model for a whole family of drug-delivery applications. This likely made CPEX more attractive.

Continue reading ‘Footstar to acquire CPEX’s Drug-Delivery Technology’

PneumRx lands $33M for Lung Device

Gearing up for a pivotal trial of its RePneu Lung Volume Reduction Coil system, Mountain View, CA-based PneumRx has $33 million in working capital commitments. Forbion Capital Partners and Endeavour Vision led the round. The company’s lung device is designed to improve lung function in emphysema patients by implanting Nitinol coils into the lungs to compress damaged tissue and restore elastic recoil to the lung, according to the company’s release.

Continue reading ‘PneumRx lands $33M for Lung Device’

Unraveling Alzheimer’s: Simple Small Molecules Could Untangle Complex Disease

New molecular tools developed at the University of Michigan show promise for “cleansing” the brain of amyloid plaques, implicated in Alzheimer’s disease.

Continue reading ‘Unraveling Alzheimer’s: Simple Small Molecules Could Untangle Complex Disease’